English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Syndax Pharmaceuticals
Press release submission
| May 24, 2020
SYNDAX PHARMACEUTICALS: ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer
Trending
+
Pharmaceuticals
Patient Daily
| Jan 6, 2025
Initiative launched against sickle cell disease in Sub-Saharan Africa
+
Pharmaceuticals
Patient Daily
| Jan 6, 2025
American Lung Association urges radon testing during National Radon Action Month
+
Pharmaceuticals
Patient Daily
| Jan 9, 2025
Research identifies diverse cell types in cochlear nucleus
+
Pharmaceuticals
Patient Daily
| Jan 10, 2025
Study reveals dynamics behind CAR T cell's ability to fight cancer
